SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-122605
Filing Date
2023-12-01
Accepted
2023-12-01 08:00:23
Documents
2
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2331870d1_6k.htm 6-K 14001
2 EXHIBIT 99.1 tm2331870d1_ex99-1.htm EX-99.1 10832
  Complete submission text file 0001104659-23-122605.txt   26020
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 231457557
SIC: 2834 Pharmaceutical Preparations